activity
20202026
most citedUnderstanding the role of phenotypic switching in cancer drug resistance

79 citations · 138 across the 10 of their papers we have counts for

collaborators

10 papers

math.PR2026

The Site Frequency Spectrum in an Exponentially Growing Population with Selection

Armaan Ahmed, Jasmine Foo, Einar Gunnarsson +1

We consider a supercritical two-type continuous-time linear birth-death process with mutation and selection, in which wild-type individuals give rise to mutant offspring with a lar…

q-bio.PE2024

Optimal dosing of anti-cancer treatment under drug-induced plasticity

Einar Bjarki Gunnarsson, Benedikt Vilji Magnússon, Jasmine Foo

While cancer has traditionally been considered a genetic disease, mounting evidence indicates an important role for non-genetic (epigenetic) mechanisms. Common anti-cancer drugs ha…

q-bio.PE2024

A statistical framework for detecting therapy-induced resistance from drug screens

Chenyu Wu, Einar Bjarki Gunnarsson, Jasmine Foo +1

Resistance to therapy remains a significant challenge in cancer treatment, often due to the presence of a stem-like cell population that drives tumor recurrence post-treatment. Mor…

math.PR2023

Limit theorems for the site frequency spectrum of neutral mutations in an exponentially growing population

Einar Bjarki Gunnarsson, Kevin Leder, Xuanming Zhang

The site frequency spectrum (SFS) is a widely used summary statistic of genomic data. Motivated by recent evidence for the role of neutral evolution in cancer, we investigate the S…

q-bio.QM2023★ 14 cited

Statistical inference of the rates of cell proliferation and phenotypic switching in cancer

Einar Bjarki Gunnarsson, Jasmine Foo, Kevin Leder

Recent evidence suggests that nongenetic (epigenetic) mechanisms play an important role at all stages of cancer evolution. In many cancers, these mechanisms have been observed to i…

q-bio.PE2023

Using birth-death processes to infer tumor subpopulation structure from live-cell imaging drug screening data

C. Wu, E. B. Gunnarsson, E. M. Myklebust +6

Tumor heterogeneity is a complex and widely recognized trait that poses significant challenges in developing effective cancer therapies. In particular, many tumors harbor a variety…

q-bio.PE2022

Dynamics of advantageous mutant spread in spatial death-birth and birth-death Moran models

Jasmine Foo, Einar Bjarki Gunnarsson, Kevin Leder +1

The spread of an advantageous mutation through a population is of fundamental interest in population genetics. While the classical Moran model is formulated for a well-mixed popula…

q-bio.PE2021★ 42 cited

Exact site frequency spectra of neutrally evolving tumors: a transition between power laws reveals a signature of cell viability

Einar Bjarki Gunnarsson, Kevin Leder, Jasmine Foo

The site frequency spectrum (SFS) is a popular summary statistic of genomic data. While the SFS of a constant-sized population undergoing neutral mutations has been extensively stu…

math.PR2020★ 3 cited

Spread of premalignant mutant clones and cancer initiation in multilayered tissue

Jasmine Foo, Einar Bjarki Gunnarsson, Kevin Leder +1

Over 80% of human cancers originate from the epithelium, which covers the outer and inner surfaces of organs and blood vessels. In stratified epithelium, the bottom layers are occu…

q-bio.PE2020★ 79 cited

Understanding the role of phenotypic switching in cancer drug resistance

Einar Bjarki Gunnarsson, Subhajyoti De, Kevin Leder +1

The emergence of acquired drug resistance in cancer represents a major barrier to treatment success. While research has traditionally focused on genetic sources of resistance, rece…